Innate Pharma (IPHA) Interest Coverage Ratio (2019 - 2025)
Innate Pharma posted quarterly Interest Coverage Ratio of 16.76 for Q4 2025, up 24.66% year-on-year from 13.45 in Q4 2024, and up 84.78% on a QoQ basis from 9.07 in Q2 2025.
Innate Pharma (IPHA) has 7 years of Interest Coverage Ratio data on file, last reported at 16.76 in Q4 2025.
- For the quarter ending Q4 2025, Interest Coverage Ratio rose 24.66% year-over-year to 16.76; the trailing twelve-month figure through Dec 2025 stood at 13.19 (up 30.48% YoY), and the FY2025 full-year result was 17.31, down 33.41% from the prior year.
- Interest Coverage Ratio for Q4 2025 stood at 16.76, up from 9.07 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 16.76 in Q4 2025 and bottomed at 0.41 in Q2 2023.
- The 5-year median for Interest Coverage Ratio is 11.93 (2021), against an average of 10.18.
- The widest annual swing landed in 2023, when Interest Coverage Ratio tumbled 56.91%; it then jumped 2994.25% in 2024.
- A 5-year view of Interest Coverage Ratio shows it stood at 11.97 in 2021, then declined by 0.59% to 11.89 in 2022, then sank by 56.91% to 5.13 in 2023, then soared by 162.33% to 13.45 in 2024, then increased by 24.66% to 16.76 in 2025.
- The last three Interest Coverage Ratio figures came in at 16.76 (Q4 2025), 9.07 (Q2 2025), and 13.45 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | -129.79 |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | 3.58 |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | -258.33 |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | - |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 49.84 |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | 11.50 |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 3.88 |
| 10 | Innate Pharma | 199.64 Mn | 199.64 Mn | - | 16.76 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 16.76 |
| Jun 30, 2025 | 9.07 |
| Dec 31, 2024 | 13.45 |
| Jun 30, 2024 | 12.75 |
| Dec 31, 2023 | 5.13 |
| Jun 30, 2023 | 0.41 |
| Dec 31, 2022 | 11.89 |
| Dec 31, 2021 | 11.97 |
| Dec 31, 2020 | 1.12 |
| Jun 30, 2020 | 1.88 |
| Dec 31, 2019 | 5.17 |